Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2014, Article ID 946265, 5 pages
http://dx.doi.org/10.1155/2014/946265
Research Article

Detection of Impaired Cognitive Function in Rat with Hepatosteatosis Model and Improving Effect of GLP-1 Analogs (Exenatide) on Cognitive Function in Hepatosteatosis

1Department of Physiology, Faculty of Medicine, Gaziosmanpasa University, Tokat, Turkey
2Department of Internal Medicine, School of Medicine, Ege University, Izmir, Turkey
3Department of Geriatrics Medicine, Medical Faculty, Ege University, 5th Floor, Bornova, 35100 Izmir, Turkey
4Department of Histology and Embryology, School of Medicine, Ege University, Izmir, Turkey
5Department of Physiology, School of Medicine, Ege University, Izmir, Turkey

Received 20 September 2013; Accepted 22 January 2014; Published 11 March 2014

Academic Editors: P. Campiglia, G. Iaccarino, and N. Montuori

Copyright © 2014 Oytun Erbaş et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Tomas, J. A. Wood, V. Stanojevic, and F. Habener, “Glucagon-like peptide-1(9–36)amide metabolite inhibits weight gain and attenuates diabetes and hepatic steatosis in diet-induced obese mice,” Diabetes, Obesity and Metabolism, vol. 13, no. 1, pp. 26–33, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Luo, M. Yang, Q. Hao, J. Yue, and B. Dong, “Cross-sectional study examining the association between metabolic syndrome and cognitive function among the oldest old,” Journal of the American Medical Directors Association, vol. 14, no. 2, pp. 105–108, 2013. View at Publisher · View at Google Scholar
  3. K. F. Yates, V. Sweat, P. L. Yau, M. M. Turchiano, and A. Convit, “Impact of metabolic syndrome on cognition and brain: a selected review of the literature,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, no. 9, pp. 2060–2067, 2012. View at Publisher · View at Google Scholar
  4. Y. D. Reijmer, E. van den Berg, J. M. Dekker et al., “The metabolic syndrome, atherosclerosis and cognitive functioning in a non-demented population: the Hoorn Study,” Atherosclerosis, vol. 219, no. 2, pp. 839–845, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. A. S. Watts, N. Loskutova, J. M. Burns, and D. K. Johnson, “Metabolic syndrome and cognitive decline in early Alzheimer's disease and healthy older adults.,” Journal of Alzheimer's Disease, vol. 35, no. 2, pp. 253–265, 2013. View at Publisher · View at Google Scholar
  6. C. L. Liu, M. H. Lin, L. N. Peng et al., “Late-life metabolic syndrome prevents cognitive decline among older men aged 75 years and over: One-Year Prospective Cohort Study,” The Journal of Nutrition, Health & Aging, vol. 17, no. 6, pp. 523–526, 2013. View at Publisher · View at Google Scholar
  7. M. Muller, F. van Raamt, F. L. Visseren et al., “Metabolic syndrome and cognition in patients with manifest atherosclerotic disease: the SMART Study,” Neuroepidemiology, vol. 34, no. 2, pp. 83–89, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Hölscher, “The role of GLP-1 in neuronal activity and neurodegeneration,” Vitamins & Hormones, vol. 84, pp. 331–354, 2010. View at Publisher · View at Google Scholar
  9. X. Su, X. Feng, N. Terrando et al., “Dysfunction of inflammation-resolving pathways is associated with exaggerated postoperative cognitive decline in a rat model of the metabolic syndrome,” Molecular Medicine, vol. 18, no. 1, pp. 1481–1490, 2013. View at Publisher · View at Google Scholar
  10. M. T. Heneka, F. Nadrigny, T. Regen et al., “Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 13, pp. 6058–6063, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Hwang, H. Hwang, H.-W. Lee, and K. Suk, “Microglia signaling as a target of donepezil,” Neuropharmacology, vol. 58, no. 7, pp. 1122–1129, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Jardanhazi-Kurutz, M. P. Kummer, D. Terwel, K. Vogel, A. Thiele, and M. T. Heneka, “Distinct adrenergic system changes and neuroinflammation in response to induced locus ceruleus degeneration in APP/PS1 transgenic mice,” Neuroscience, vol. 176, pp. 396–407, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Li, T. Perry, M. S. Kindy et al., “GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 4, pp. 1285–1290, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. J. I. Oka, N. Goto, and T. Kameyama, “Glucagon-like peptide-1 modulates neuronal activity in the rat's hippocampus,” Neuroreport, vol. 10, no. 8, pp. 1643–1646, 1999. View at Google Scholar · View at Scopus
  15. M. J. During, L. Cao, D. S. Zuzga et al., “Glucagon-like peptide-1 receptor is involved in learning and neuroprotection,” Nature Medicine, vol. 9, no. 9, pp. 1173–1179, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. S. W. French, K. Miyamoto, and H. Tsukamoto, “Ethanol-induced hepatic fibrosis in the rat: role of the amount of dietary fat,” Alcoholism: Clinical and Experimental Research, vol. 10, supplement 6, pp. 13–19, 1986. View at Google Scholar · View at Scopus
  17. A. Sheludiakova, K. Rooney, and R. A. Boakes, “Metabolic and behavioural effects of sucrose and fructose/glucose drinks in the rat,” European Journal of Nutrition, vol. 51, no. 4, pp. 445–454, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Lindqvist, P. Mohapel, B. Bouter et al., “High-fat diet impairs hippocampal neurogenesis in male rats,” European Journal of Neurology, vol. 13, no. 12, pp. 1385–1388, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. G. D'Angelo, A. A. Elmarakby, D. M. Pollock, and D. W. Stepp, “Fructose feeding increases insulin resistance but not blood pressure in Sprague-Dawley rats,” Hypertension, vol. 46, no. 4, pp. 806–811, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Alzamendi, A. Giovambattista, A. Raschia et al., “Fructose-rich diet-induced abdominal adipose tissue endocrine dysfunction in normal male rats,” Endocrine, vol. 35, no. 2, pp. 227–232, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Alzamendi, D. Castrogiovanni, R. C. Gaillard, E. Spinedi, and A. Giovambattista, “Increased male offspring's risk of metabolic-neuroendocrine dysfunction and overweight after fructose-rich diet intake by the lactating mother,” Endocrinology, vol. 151, no. 9, pp. 4214–4223, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. Z. Zakula, G. Koricanac, S. Tepavcevic, M. Stojiljkovic, T. Milosavljevic, and E. R. Isenovic, “Impairment of cardiac insulin signaling in fructose-fed ovariectomized female Wistar rats,” European Journal of Nutrition, vol. 50, no. 7, pp. 543–551, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. K. R. Bruckdorfer, I. H. Khan, and J. Yudkin, “Fatty acid synthetase activity in the liver and adipose tissue of rats fed with various carbohydrates,” Biochemical Journal, vol. 129, no. 2, pp. 439–446, 1972. View at Google Scholar · View at Scopus
  24. A. E. Bergstra, A. G. Lemmens, and A. C. Beynen, “Dietary fructose vs. glucose stimulates nephrocalcinogenesis in female rats,” The Journal of Nutrition, vol. 123, no. 7, pp. 1320–1327, 1993. View at Google Scholar · View at Scopus
  25. C. Messier and N. M. White, “Memory improvement by glucose, fructose, and two glucose analogs: a possible effect on peripheral glucose transport,” Behavioral and Neural Biology, vol. 48, no. 1, pp. 104–127, 1987. View at Google Scholar · View at Scopus
  26. A. E. Petro, J. Cotter, D. A. Cooper, J. C. Peters, S. J. Surwit, and R. S. Surwit, “Fat, carbohydrate, and calories in the development of diabetes and obesity in the C57BL/6J Mouse,” Metabolism: Clinical and Experimental, vol. 53, no. 4, pp. 454–457, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. W. A. Rodriguez, C. A. Horne, A. N. Mondragon, and D. D. Phelps, “Comparable dose-response functions for the effects of glucose and fructose on memory,” Behavioral and Neural Biology, vol. 61, no. 2, pp. 162–169, 1994. View at Google Scholar · View at Scopus
  28. A. P. Ross, T. J. Bartness, J. G. Mielke, and M. B. Parent, “A high fructose diet impairs spatial memory in male rats,” Neurobiology of Learning and Memory, vol. 92, no. 3, pp. 410–416, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. E. C. Bruggeman, C. Li, A. P. Ross et al., “A high fructose diet does not affect amphetamine self-administration or spatial water maze learning and memory in female rats,” Pharmacology Biochemistry and Behavior, vol. 99, no. 3, pp. 356–364, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. B. Kreymann, G. Williams, M. A. Ghatei, and S. R. Bloom, “Glucagon-like peptide-1 7–36: a physiological incretin in man,” The Lancet, vol. 330, no. 8571, pp. 1300–1304, 1987. View at Publisher · View at Google Scholar · View at Scopus
  31. B. Ahren, H. Larsson, and J. J. Holst, “Effects of glucagon-like peptide-1 on islet function and insulin sensitivity in noninsulin-dependent diabetes mellitus,” The Journal of Clinical Endocrinology & Metabolism, vol. 82, no. 2, pp. 473–478, 1997. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Perry, H. W. Holloway, A. Weerasuriya et al., “Evidence of GLP-1-mediated neuroprotection in an animal model of pyridoxine-induced peripheral sensory neuropathy,” Experimental Neurology, vol. 203, no. 2, pp. 293–301, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Oka, E. Suzuki, N. Goto, and T. Kameyama, “Endogenous GLP-1 modulates hippocampal activity in β-amyloid protein-treated rats,” Neuroreport, vol. 10, no. 14, pp. 2961–2964, 1999. View at Google Scholar · View at Scopus
  34. S. Gengler, P. L. McClean, R. McCurtin, V. A. Gault, and C. Hölscher, “Val(8)GLP-1 rescues synaptic plasticity and reduces dense core plaques in APP/PS1 mice,” Neurobiology of Aging, vol. 33, no. 2, pp. 265–276, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. A. J. Kastin, V. Akerstrom, and W. Pan, “Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier,” Journal of Molecular Neuroscience, vol. 18, no. 1-2, pp. 7–14, 2002. View at Google Scholar · View at Scopus
  36. S. Chen, A. R. Liu, F. M. An, W. B. Yao, and X. D. Gao, “Amelioration of neurodegenerative changes in cellular and rat models of diabetes-related Alzheimer's disease by exendin-4,” Age, vol. 34, no. 5, pp. 1211–1224, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. V. A. Gault, W. D. Porter, P. R. Flatt, and C. Hölscher, “Actions of exendin-4 therapy on cognitive function and hippocampal synaptic plasticity in mice fed a high-fat diet,” International Journal of Obesity, vol. 34, no. 8, pp. 1341–1344, 2010. View at Publisher · View at Google Scholar · View at Scopus